- Reaction score
- 5
Isn't Replicel using a similar method to what Aderans used? Look at the second paragraph, it states that in their phase 2 trial that they found that their treatment prevented future hairloss. I know that Aderans was discontinued but this shows that RCH-01 can offer maintenance as shown in Aderans' phase 2 results. I also understand that the DP lose inductivity in mass culture, but could the cultured cells still retain the DHT-resistant genes and pass them on to the inductive cells in the follicle? I'm no scientist, but it makes sense to me.
Last edited: